Clinical trial
Prostate Cancer in Benign Prostatic Hyperplasia (BPH) Patients
NCT01767363 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostate Cancer in Benign Prostatic Hyperplasia (BPH) Patients
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- March 31, 2016
- Enrollment
- 1 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.